Post-hoc analysis evaluates motor complications in early Parkinson’s patients treated with Opicapone and levodopa outcomes.
This post-hoc analysis of EPSILON study evaluated whether levodopa dose and timing of Opicapone initiation (double-blind [DB] vs open-label extension [OLE] baseline) influenced the risk of motor complications (MCs) over 1.5 years.
No takes yet. Share an insight, caveat, or question.
Ferreira et al. (2026) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: